Modest rescue of RBFOX1 splicing function attenuates Huntington's disease features.
Overview
- Center for Molecular Biology Severo Ochoa (CBM Severo Ochoa) CSIC/UAM, C/ Nicolás Cabrera, 1, Madrid, 28049 Spain
- Networking Biomedicine Research Center on Neurodegenerative Diseases (CIBER-NED), Instituto de Salud Carlos III,Madrid, 28031 Spain
Abstract
Background: RNA mis-splicing underlies a growing number of neurological disorders and, consequently, splicing correction therapies have been developed for some monogenic forms, like spinal muscular atrophy or neuronal ceroid lipofuscinosis. In Huntington’s disease (HD), alternative splicing alteration emerged as a molecular mechanism in view of individually reported mis-splicing events in neurodegeneration-linked
Methods: We performed RT-PCR and Western blot analyses of RBFOX in post-mortem brain samples from HD patients and mice. We generated transgenic mouse lines overexpressing RBFOX1 in forebrain neurons and performed RNA-seq to analyze its impact on HD-associated mis-splicing. In addition, we combined HD mice with RBFOX1-overexpressing mice to verify correction of Rbfox1 levels and mis-splicing of RBFOX target genes, and performed histopathological and motor behavioral analyses.
Results: We observed that decreased expression of Rbfox1 in striatum of HD mice at early stages of disease progression correlates with a reduction of Rbfox1 immunostaining particularly in the nucleus. This prompted us to generate transgenic mouse lines overexpressing the nuclear isoform of RBFOX1. The overexpression of RBFOX1 in this new transgenic mouse line induced widespread alternative splicing changes that significantly overlapped with genes mis-spliced in brains of both HD patients and mouse models. We found that moderate neuronal RBFOX1 overexpression in HD mice results in correction of several HD-associated mis-splicing events and in attenuation of neurodegeneration and motor symptoms.
Conclusions: These results demonstrate that the observed decrease of RBFOX1 levels in brains of HD patients and mice contributes to HD pathogenesis and suggest therapeutic potential of RBFOX-increasing strategies for HD.
Supplementary Information: The online version contains supplementary material available at 10.1186/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- figshare:31986374, at figshare; found in DataCite
- figshare:31986377, at figshare; found in DataCite
- figshare:31986380, at figshare; found in DataCite
Data availability
Data generated in this study are available from the corresponding author upon reasonable request. The RNA-seq dataset will be available at the European Nucleotide Archive (ENA) database with accession number PRJEB110930.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 13 MeSH terms, 1 funder, 50 references.
Cite
This paper
Lozano-Muñoz, D., Elorza, A., Lucas-Santamaría, M., Santos-Galindo, M., Parras, A., & Lucas, J. J. (2026). Modest rescue of RBFOX1 splicing function attenuates Huntington's disease features. Molecular medicine (Cambridge, Mass.), 32(1), 56. https://
BibTeX
@article{lozanomunoz2026
author = {Lozano-Muñoz, David and Elorza, Ainara and Lucas-Santamaría, Miriam and Santos-Galindo, María and Parras, Alberto and Lucas, José J.},
title = {{Modest rescue of RBFOX1 splicing function attenuates Huntington's disease features}},
journal = {Molecular medicine (Cambridge, Mass.)},
year = {2026},
month = apr,
volume = {32},
number = {1},
pages = {56},
publisher = {The Feinstein Institute for Medical Research},
issn = {1076-1551},
doi = {10.1186/
url = {https://
pmid = {41928095},
pmcid = {PMC13067610}
}
RIS
TY - JOUR
AU - Lozano-Muñoz, David
AU - Elorza, Ainara
AU - Lucas-Santamaría, Miriam
AU - Santos-Galindo, María
AU - Parras, Alberto
AU - Lucas, José J.
TI - Modest rescue of RBFOX1 splicing function attenuates Huntington's disease features
T2 - Molecular medicine (Cambridge, Mass.)
J2 - Mol Med
PY - 2026
DA - 2026/
VL - 32
IS - 1
SP - 56
SN - 1076-1551
PB - The Feinstein Institute for Medical Research
DO - 10.1186/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1186/
"type": "article-journal",
"title": "Modest rescue of RBFOX1 splicing function attenuates Huntington's disease features",
"container-title": "Molecular medicine (Cambridge, Mass.)",
"author": [
{
"family": "Lozano-Muñoz",
"given": "David"
},
{
"family": "Elorza",
"given": "Ainara"
},
{
"family": "Lucas-Santamaría",
"given": "Miriam"
},
{
"family": "Santos-Galindo",
"given": "María"
},
{
"family": "Parras",
"given": "Alberto"
},
{
"family": "Lucas",
"given": "José J."
}
],
"container-title-short":
"volume": "32",
"issue": "1",
"page": "56",
"DOI": "10.1186/
"PMID": "41928095",
"PMCID": "PMC13067610",
"ISSN": "1076-1551",
"publisher": "The Feinstein Institute for Medical Research",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
2
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41586-024-08289-w [code]
- Mis-splicing of a neuronal microexon promotes CPEB4 aggregation in ASD.Journal: NatureIn common: mouse, 6 references, author José J. Lucas
- [2] doi:10.1038/s41467-023-39936-x
- Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's disease.Journal: Nature communicationsIn common: other condition, mouse, 7 references
- [3] doi:10.1016/j.ebiom.2023.104720 [code]
- Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease.Journal: EBioMedicineIn common: histology / microscopy, other condition, mouse, 6 references
- [4] doi:10.1101/gr.275245.121
- RBFOX splicing factors contribute to a broad but selective recapitulation of peripheral tissue splicing patterns in the thymus.Journal: Genome researchIn common: mouse, 6 references
- [5] doi:10.1093/braincomms/fcac248 [code]
- Mutant huntingtin messenger RNA forms neuronal nuclear clusters in rodent and human brains.Journal: Brain communicationsIn common: histology / microscopy, other condition, mouse, 5 references
- [6] doi:10.1093/brain/awad329
- Widespread alternative splicing dysregulation occurs presymptomatically in CAG expansion spinocerebellar ataxias.Journal: Brain : a journal of neurologyIn common: other condition, mouse, 5 references
- [7] doi:10.1186/s11658-026-00948-2 [code]
- Phosphoproteomic profiling reveals post-translational dysregulation in Huntington's disease patient-derived neurons.Journal: Cellular & molecular biology lettersIn common: other condition, 5 references
- [8] doi:10.1093/hmg/ddad125
- Arginine methylation of RNA-binding proteins is impaired in Huntington's disease.Journal: Human molecular geneticsIn common: other condition, 5 references
- [9] doi:10.1038/s41593-024-01850-w
- Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification.Journal: Nature neuroscienceIn common: other condition, mouse, 5 references
- [10] doi:10.1016/j.ebiom.2024.105124
- The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ.Journal: EBioMedicineIn common: other condition, 1 reference, author José J. Lucas
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
